Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2021-03-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Discontinuous Echocardiographic Subcostal Cardiac Output Measurement
NCT07177391
Comparability of Hemodynamic Parameters Measured by Non-invasive Echocardiography and by Right Heart Catheterization
NCT03231774
Validation of Automated Cardiac Output Measurement
NCT03372863
Impact of Simulator-based Training in Transoesophageal Echocardiography
NCT02537639
Safety, Feasibility and Clinical Utility of Critical Care Transesophageal Echocardiography in Hong Kong
NCT06178471
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To assess the correlation and feasibility of real-time automatic continuous cardiac output measurements using transthoracic ultrasound (TTE) in adult ICU-patients in comparison to Flotrac measurements
Study design: prospective, feasibility study
Study population: Adult Intensive Care patients ( \> 18 years)
Intervention (if applicable):
Consecutive adult patients on the ICU in which the there is an indication for continuous cardiac output measurements.
Main study parameters/endpoints:
* Percentage of patients in which continuous cardiac output can be measured using TTE
* Correlation between continuous TTE and Flotrac measurements
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardiac output measurements
Cardiac output will be measured using TTE continuously with ProbeFix
TTE
Transthoracic echocardiography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TTE
Transthoracic echocardiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Atrial fibrillation or other irregular heart rhythm
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rijnstate Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RijnstateH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.